Literature DB >> 17306674

Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images.

Kaoru Funaki1, Hidenobu Fukunishi, Tsuyoshi Funaki, Katsuhiro Sawada, Yasushi Kaji, Takeshi Maruo.   

Abstract

OBJECTIVE: This study was undertaken to clarify the relationship between the signal intensity of T2-weighted magnetic resonance images and the therapeutic effect of magnetic resonance-guided focused ultrasound surgery (MRgFUS) on uterine fibroids. STUDY
DESIGN: Ninety-five fibroids in 63 patients were classified into 3 types based on the signal intensity of T2-weighted magnetic resonance images as follows: type 1, low intensity; type 2, intermediate intensity; type 3, high intensity. The treated area ratio of MRgFUS and the volume reduction ratio 6 months after treatment were used as the indices of therapeutic effect.
RESULTS: The treated area ratio of type 3 fibroids was the lowest among the 3 types (P < .01). The volume reduction ratio correlated with the treated area ratio (r = 0.64; P < .01).
CONCLUSION: The efficacy of MRgFUS correlates with the signal intensity of T2-weighted magnetic resonance images. Type 1 and type 2 fibroids are suitable candidates for MRgFUS, whereas type 3 fibroids are not.

Entities:  

Mesh:

Year:  2007        PMID: 17306674     DOI: 10.1016/j.ajog.2006.08.030

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  74 in total

1.  Comparison between diffusion-weighted imaging, T2-weighted, and postcontrast T1-weighted imaging after MR-guided, high intensity, focused ultrasound treatment of uterine leiomyomata: preliminary results.

Authors:  Michael A Jacobs; David H Gultekin; Hyun S Kim
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

2.  Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images.

Authors:  Wen-Peng Zhao; Jin-Yun Chen; Wen-Zhi Chen
Journal:  Exp Ther Med       Date:  2015-11-18       Impact factor: 2.447

Review 3.  MR-guided focused ultrasound surgery, present and future.

Authors:  David Schlesinger; Stanley Benedict; Chris Diederich; Wladyslaw Gedroyc; Alexander Klibanov; James Larner
Journal:  Med Phys       Date:  2013-08       Impact factor: 4.071

4.  The role of T1 perfusion-based classification in magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids.

Authors:  Bilgin Keserci; Nguyen Minh Duc
Journal:  Eur Radiol       Date:  2017-06-14       Impact factor: 5.315

Review 5.  Reproductive impact of MRI-guided focused ultrasound surgery for fibroids: a systematic review of the evidence.

Authors:  Natalie A Clark; Sunni L Mumford; James H Segars
Journal:  Curr Opin Obstet Gynecol       Date:  2014-06       Impact factor: 1.927

Review 6.  Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids.

Authors:  Nguyen Minh Duc; Bilgin Keserci
Journal:  Diagn Interv Radiol       Date:  2018-09       Impact factor: 2.630

Review 7.  Clinical and Technical Aspects of MR-Guided High Intensity Focused Ultrasound for Treatment of Symptomatic Uterine Fibroids.

Authors:  Laura E Rueff; Steven S Raman
Journal:  Semin Intervent Radiol       Date:  2013-12       Impact factor: 1.513

8.  MR-guided transcranial brain HIFU in small animal models.

Authors:  B Larrat; M Pernot; J-F Aubry; E Dervishi; R Sinkus; D Seilhean; Y Marie; A-L Boch; M Fink; M Tanter
Journal:  Phys Med Biol       Date:  2009-12-17       Impact factor: 3.609

Review 9.  Update on Clinical Magnetic Resonance-Guided Focused Ultrasound Applications.

Authors:  Thiele Kobus; Nathan McDannold
Journal:  Magn Reson Imaging Clin N Am       Date:  2015-07-07       Impact factor: 2.266

10.  Pregnancy and natural delivery following magnetic resonance imaging-guided focused ultrasound surgery of uterine myomas.

Authors:  Sang-Wook Yoon; Kyoung Ah Kim; Sang Heum Kim; Doo Hoe Ha; Chan Lee; Sun Young Lee; Sang-Geun Jung; Seung-Jo Kim
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.